"Promising Results: Experimental Cancer Vaccine Shows 40% Success Rate in Pancreatic Tumors"

An experimental cancer vaccine developed by researchers at the University of Massachusetts has shown promising results in treating pancreatic tumors, clearing 43% of tumors in mice and preventing relapse. The vaccine uses a weakened salmonella bacteria to stimulate an immune response and contains a piece of the recipient's tumor to train the body to fight the cancer. While the study is preliminary and on mice, the team hopes to start human trials in the coming years. If approved, this vaccine could provide a lifeline for patients with pancreatic cancer, which currently has a low survival rate.